Shown is a 3D rendering of a human male upper body in a glowing blue that is translucent showing the internal central organs with the pancreas highlighted in orange.
Pancreatic cancer is one of the deadliest forms of Cancer with a survival rate of only 3 to 5 percent.
Current chemotherapy treatments for pancreatic cancer have limited effect. Gemcitabine is the drug most often used to treat metastatic, unresectable pancreatic cancer.
Therapeutic Solution
A novel compound (AS-10) that is selectively toxic to cancer cells, inducing apoptosis (cell death) and in a mouse model found to inhibit tumor growth in pancreatic cancer.
Compound is more than 100 times more potent than gemcitabine.